This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Society news


BJCP article: Are antivirals a cost-effective therapy during severe flu seasons?

08 Feb 2017

A new study indicates that the antiviral drug oseltamivir can reduce influenza infections and prevent deaths in a cost-saving manner under most pandemic scenarios.  

BJP article: Could drugs replace gastric bypass surgery?

08 Feb 2017

In an attempt to reduce nutrient absorption and replicate the effects of gastric bypass surgery, researchers screened for inhibitors of an amino acid transporter, called B0AT1, and discovered a number of agents—including benztropine, a drug that is already in clinical use—as promising candidates.

The Society’s campaign on clinical pharmacology & the NHS mentioned in House of Lords

23 Jan 2017

During proceedings on 23 January 2017, peers in the House of Lords drew attention to the British Pharmacological Society’s ongoing campaign on clinical pharmacology & the NHS in discussions with the new Parliamentary Under-Secretary of State, Department of Health (Lord O'Shaughnessy).  

BJCP article: Dietary supplement may carry both benefits and risks associated with statins

17 Jan 2017

Red yeast rice (RYR) is contained in dietary supplements that are often used by patients with high cholesterol, and it is often proposed as an alternative therapy in those who experience side effects from statins. A new study found that it is not a good choice for statin-intolerant patients: RYR was linked with muscle and liver injury, which can also occur with statin use.

International Advisory Group launched

09 Jan 2017

As part of the Society’s charitable mission to promote and advance the spectrum of pharmacology, we are committed to fulfilling the needs of our members regardless of geography – and the International Advisory Group will play an important role in supporting this.

New winners of prizes and awards announced

06 Jan 2017

Congratulations to the winners of the Society's prizes and awards judged and/or announced during our annual meeting Pharmacology 2016.

BJCP article: Acid suppression medications linked to serious gastrointestinal infections

05 Jan 2017

In a population-based study from Scotland, use of commonly-prescribed acid suppression medications such as proton pump inhibitors (PPIs) was linked with an increased risk of intestinal infections.

Pharmacology mentioned in House of Common's debate on exiting the EU

20 Dec 2016

The Society is pleased to report that its evidence on the impact of exiting the European Union (EU) was highlighted during a House of Commons debate on 19 December 2016. This followed our ongoing engagement activity with MPs with a special interest in science and health, including our written submission on "Leaving the EU" to the recent inquiry by the House of Commons' Science & Technology Committee.

BJCP article: Efforts Are Needed to Optimize the Use of Biologics for Treating Patients with Rheumatoid Arthritis

19 Dec 2016

The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.

New Honorary Fellows & Fellows announced

14 Dec 2016

Contributions across pharmacology and related fields honoured.

'Next generation' precision medicine for cystic fibrosis wins prestigeous drug discovery award

14 Dec 2016

A new medicine to treat cystic fibrosis has received Drug Discovery of the Year 2017, a prestigious award from the British Pharmacological Society. A combination of two drugs (lumacaftor and ivacaftor) offers a significant step forward for the treatment of this life-limiting, inherited disease. The award is made to the team of researchers at pharmaceutical company Vertex Pharmaceuticals, which is responsible for the development of lumacaftor/ivacaftor, in recognition of the drug offering an innovative approach that addresses a significant unmet medical need.